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Case report
Basaloid squamous cell carcinoma of the larynx: 
report of a early laryngeal cancer
Carcinoma squamocellulare basaloide della laringe: case report di uno stadio 
precoce
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SummAry
Basaloid squamous cell carcinoma is a recently recognized, rare and aggressive variant of squamous cell carcinoma with a predilection to 
occur in base of the tongue, hypopharynx and larynx (especially the supraglottic tract). it is usually diagnosed in advanced stage, frequently 
with distant metastases, requiring aggressive surgical intervention. The prognosis is remarkably poor even after the association of radio-
therapy or chemotherapy. nevertheless recently it has been reported that in the early stage this neoplasm seems to have a behaviour less 
aggressive, similar to conventional squamous carcinoma. The therapeutic approach is not clearly defined when the neoplasm is diagnosed 
at an early stage. We present a case of early stage of basaloid squamous cell carcinoma of the supraglottic larynx.
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riASSunTo
Il carcinoma squamoso basaloide è una variante, recentemente codificata, rara ed aggressiva del carcinoma a cellule squamose con lo-
calizzazione preferenziale a livello della base lingua, ipofaringe e laringe (in particolar modo la porzione sovraglottica). Nella maggior 
parte dei casi è diagnosticato in stadi avanzati, frequentemente con presenza di metastasi a distanza, che richiedono interventi chirurgici 
demolitivi. La prognosi è solitamente infausta anche dopo associazione di terapia chirurgica e radioterapica. Recentemente, tuttavia, 
secondo vari studi tale neoplasia negli stadi iniziali sembra avere un comportamento meno aggressivo, simile a quello del carcinoma squa-
mocellulare classico. In tali stadi precoci l’approccio terapeutico non è ancora chiaramente definito. Presentiamo la nostra esperienza in 
un caso di carcinoma basaloide del laringe ad uno stadio iniziale
PArole ChiAve: Tumori della laringe • Sopraglottide • Carcinoma squamoso basaloide  • Radioterapia
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Introduction
Basaloid  squamous  cell  carcinoma  (BSCC)  is  a  high-
grade variant of squamous cell carcinoma (SCC), with a 
frequent localization in head and neck. The most frequent 
sites of occurrence in the upper aero-digestive tract are 
oropharynx (base of tongue), hypopharynx (pyriform si-
nus) and supraglottic larynx 1-4.
Although  BSCC  has  predilection  for  cervico-facial  re-
gion, it can also occur at other sites such as oesophagus, 
lung, thymus, anus and cervix uteri 5-9.
Wain et al. recognized the BSCC as a separate variant of 
SCC in 1986 and since then only few tens of cases of la-
ryngeal localizations have been reported 10.
it affects mainly men in sixth or seventh decade of life, with 
frequent cervical node metastases at presentation 11 12.
The clinical presentation is similar to other laryngeal car-
cinomas, but especially in supraglottic localizations the 
diagnosis is of advanced laryngeal cancer classified by 
American Joint Committee 8 13 14.
metastases in loco-regional nodes are reported in 64% of 
patients and disseminated spread (lung, liver, bone, brain 
and skin) in 44% of cases 3.
The diagnosis is often delayed so that reasonable treat-
ment options are radical surgery, chemoradiation or radia-
tion alone (5 years survival is reported to be 17.5%) 13 14.
in early BSCC the neoplasm appears to have a behaviour 
less aggressive similar to conventional SCC 15 16.
We would like to report a case of T1 stage BSCC of the 
supraglottic larynx.  
Case report
S.l., a 50 year-old woman, presented to our enT depart-
ment complaining a moderate hoarseness. She was a moder-F. Soprani et al.
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ate smoker by several years; the medical history was nega-
tive. A videofiberlaryngoscopy revealed the presence of a 
polypoid mass of the medial margin right (anterior third) of 
the right false vocal fold, with an aspect of a papillomatous 
like lesion (Fig. 1). The laryngeal mobility was normal as 
well as the other portions of the upper aero-digestive tract.
The patient underwent direct microlaryngoscopy under 
general anaesthesia with macroscopically wide excision 
of the mass with sharp dissection and bleeding control 
with monopolar needle dedicated instrument.
histological examination revealed the presence of a BSCC 
of the supraglottic larynx (Fig. 2).
A computed tomography (CT) scan of neck and thorax 
was negative (Fig. 3). We have chosen CT rather than 
magnetic resonance (mri) considering that the patient 
complained claustrophobia.
Also  a  total-body  [18F]-2-fluorodeoxyglucose-PeT 
(Fdg-PeT) was negative for distant metastases.
The neoplasm was consequently classified as pT1n0m0 
Tnm stage.
For the choice of the best therapeutic strategy, considering 
on one hand the aggressiveness of this kind of tumor and 
on the other hand the very limited extension and the age 
of the patient, we have decided, rather than for a surgical 
option (partial reconstructive laryngectomy), to execute 
an external radical radiotherapy.
After collegiate evaluation, the patient underwent postop-
erative treatment with external radical radiotherapy.
A CT simulation have been done, after immobilization of 
the patient with thermoplastic mask, in supine position.
We have acquired slices of 5 mm thickness from temporo-
mandibular joint to supraclavicular fossa.
The slices have been contoured using a treatment plan-
ning sistem Pinnacle 3 (AdAC Philips).
We have contoured a Clinical Target volume (CTv), con-
sidering as CTv1 the larynx and as CTv2 the nodes of 
ii  and  iii  level  bilaterally,  following  the  radiotherapy 
oncology group (rTog) consensus guidelines (rTog 
91-11).
A total dose 60 gy for CTv1 and 44 gy for CTv2 was 
administered in 30 fractions, both at isocenter.
The treatment was not interrupted with good clinical tol-
erance; at the end of the therapy we reported grade 1 mu-
cositis of the larynx and a grade 1 dermatitis of the neck 
region  (following  the  rTog  criteria)  with  a  moderate 
dysphonia, resolved in few weeks 17.
After a follow up period of 36 months the patient is free 
from disease as confirmed by laryngeal endoscopy, CT 
scan and Fdg-PeT.
Fig. 3. Negative computed tomography (CT) scan of neck. Fig. 1. Videolaryngoscopy image showing a polypoid mass of the right false 
vocal fold.
Fig. 2. Histological examination revealing the typical aspects of a BSCC of 
the supraglottic larynx.Basaloid squamous cell carcinoma of the larynx
183
Discussion
The basaloid subtype of SCC represents less than 1% of 
laryngeal carcinomas; to our knowledge since it was rec-
ognized in 1986 as a separate entity approximately 170 
cases of BSCC were reported in literature and one fourth 
of them were located in the larynx, with a predilection 
of supraglottic tract; very few cases between these, cases 
with exclusive supraglottic involvement diagnosed at ear-
ly stage are very rare 15 16 18.
BSCC has typical histopathologic features; it is consid-
ered an highly malignant laryngeal tumor characterized 
by areas of typical in situ and/or invasive SCC associated 
with nests of small crowded cells. These cells have typi-
cally hyperchromatic nuclei, scant cytoplasm, small cystic 
spaces, necrosis, prominent hyalinisation and peripheral 
palisading. The overall appearance suggests an attempt of 
differentiation toward glandular structures 10 13 19-22.
many authors agree with Wain et al. that BSCC derives 
from totipotential cells located at the base of the ciliated 
columnar epithelium or in the proximal salivary gland 
ducts, cells that are also precursor of squamous carcino-
ma, adenocarcinoma, oat cell carcinoma and reverse cell 
carcinoma 10 19 23.
differential diagnosis should mainly include conventional 
SCC, small cell neuroendocrine carcinoma, adenoid cyst-
ic carcinoma, basal cell adenocarcinoma, adenosquamous 
carcinoma, spindle cell squamous carcinoma, mucoepi-
dermoid carcinoma and adenoid squamous cell carcino-
ma 1 8 13 15 24.
differential diagnosis is relevant because BSCC differ in 
biological behaviour, prognosis and therapeutic manage-
ment 1 8 11 14 15 24 25.
even if there is some report that BSCC can be diagnosed 
by fine needle aspiration, it is well recognized the impor-
tance of obtaining a biopsy specimen as deep and wide as 
possible (because basaloid cells could not be included in 
the specimen and so it should be difficult to distinguish 
especially between adenoid cystic carcinoma and small 
cell undifferentiated carcinoma) 3 11 24 25. 
endoscopically BSCC is indistinguishable from the com-
mon forms of squamous cancer or, such happened in our 
case, even from a papillomatous mass. 
The tumor borders are indiscreet because of their infiltra-
tive  growth  beneath  the  surface  epithelium;  this  feature 
make the neoplasm often deeply invasive and consequently 
multifocal or metastatic even at initial presentation 8 13 19 23.
Becker et al. in 1998 observed in cases of BSCC a dis-
tinct radiological aspect at magnetic resonance imaging 
(mri) consisting in a typical “lobulated” enhancement 
pattern on contrast-enhanced T1-weighted Spin echo im-
ages; the authors did not observed this particular aspect in 
the common form of SCC, which typically shows a rela-
tively homogenous enhancement with or without associ-
ated area of ulceration or necrosis 23.
Another important instrument that can be helpful in de-
tecting, staging and following BSCC of the head and neck 
area is represented by Fdg-PeT. 
Kunkel et al. demonstrated that Fdg-PeT screening was 
able to depict a clinically and radiologically invisible site 
of recurrence allowing for salvage surgery and that nor-
malized posttreatment glucose metabolism was predic-
tive for tumor control even in the “high risk population of 
BSCC patients” 26.
After the diagnosis and staging the suggested treatment in 
literature is a combination of radical surgery followed by 
radiation and chemotherapy, especially in presence of me-
tastases, considering that most of reports agree that BSCC 
is a biologically high grade malignancy with a tendency 
for locally aggressive behaviour and early regional and 
distant metastases, with a poor prognosis 1 4 8 10-16 18-20 24 27.
Ferlito, furthermore, found that this neoplasm show a ten-
dency for the development of second primary tumors in 
the upper aerodigestive tract 13.
For erdamar et al. the survival rate of BSCC was poorer 
(even if not statistically significant) compared with con-
ventional SCC; they determined moreover that, in com-
parison with the control group, for patients with supra-
glottic T2 disease and undergoing partial laryngectomy 
exists a statistically significant differences for local re-
currences with the consequence that conservative laryn-
geal surgery should be employed only with great caution. 
They concluded that postoperative irradiation should be 
encouraged as an appropriate therapy against local ag-
gressivity of tumor; in addition to local control, adjuvant 
chemotherapy should also be considered for prevention of 
distant metastases 27.
The poor prognosis of BSCC justifies an aggressive treat-
ment: more specific antibasaloid chemotherapeutic drugs 
should be sought 18.
despite these studies referring to BSCC such us a par-
ticularly aggressive pathology, some other authors sug-
gest that behaviour of BSCC, especially in early stage, is 
similar to conventional squamous cell carcinoma.
A study by luna et al. revealed that notwithstanding its 
aggressiveness, the biologic course of BSCC is similar to 
that of conventional SCC when clinical stage, site, and 
treatment are matched, emphasizing in particular that sur-
vival and incidence of cervical lymph node metastases 
were similar to those of conventional SCC 28.
The concept that an early stage of tumor may be regarded 
as a different category and treated more conservatively is 
also emphasized in three others studies 15 20 29.
For Sheen et al. although BSCC of the upper aerodiges-
tive tract is aggressive, an early glottic type of tumor may 
be regarded as a different category and treated more con-
servatively 29.
in its study erisen et al. found that their early stage cases 
with no evidence of neck nodes metastases (n0) had a good 
prognosis. even if their cases with advanced stage cancer F. Soprani et al.
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with pathologically n+ necks had poor prognosis despite 
aggressive  combined  treatment,  the  authors  believe  that 
early stage BSCC act similarly to their counterparts in con-
ventional SCC, justifying a more conservative treatment.
in the study of Alkan et al., in contrast to the literature, the 
two cases of BSCC of the larynx reported were both young 
and had no metastatic spread to cervical nodes even with 
a presentation in advanced stage (both n0); after a follow 
up of at least 24 months, following a surgical and radiant 
treatment, the patients are free of disease 20.
Because most cases of BSCC present with advanced stage 
tumor it is generally believed that histological features 
were reflective of the neoplasm’s aggressive clinical be-
haviour and poor prognosis. 
very  few  cases  of  early  stage  BSCC  are  described  in 
literature and at our knowledge there is not a sufficient 
number of case to evaluate the prognosis of this initial 
neoplasia;  greater  number  of  patients  must  be  studied 
comparing BSCC and conventional SCC matching site of 
occurrence, stage and age of presentation.
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